GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL — GOAL QuERI  

Dyslipidemia Clinical Trial

Official title: Guidelines Oriented Approach to Lipid Lowering Quality Enhancement Research Initiative (GOAL QuERI) International

Status Active, not recruiting

Clinical Trial Summary

This Quality Enhancement Research Initiative (QuERI) is a knowledge translation medical practice activity based on decision making support through feedback to physicians on their management of dyslipidemia in order to achieve guidelines recommended LDL-C levels in high risk patients. Physician interaction has three distinct components:

1. Capture of data as reported by participating physician;

2. Highlight (by providing feedback) where management may be optimized based on guidelines or recommendations;

3. Identify challenges faced by physicians resulting in the care gap..

Clinical Trial Description

The GOAL QuERI International will engage approximately 115 health care practitioners (HCP) who will enroll up to 2500 patients with management observations based on four visits by the patients in an outpatient setting. The timing of the visits will be baseline, 6±2 months, 12±2 months, and 18±2 months during which patient management by their physician will be captured using the electronic data capture form (DCF). The DCF will be created and managed by the CHRC. ;

Related Conditions & MeSH terms

• Dyslipidemia
• Dyslipidemias

• NCT number: NCT03861533
• Study type: Observational [Patient Registry]
• Source: Canadian Heart Research Centre
• Status: Active, not recruiting
• Start date: April 1, 2019
• Completion date: April 1, 2023